COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 903
[85] Selvin, E., Steffes, M. W., Zhu, H., et al. (2010). Glycated
hemoglobin, diabetes, and cardiovascular risk in nondiabetic
adults. New England Journal of Medicine, 362(9), 800-811.
[86] Crane, P. K., Walker, R., Hubbard, R. A., et al. (2013). Glucose
levels and risk of dementia. New England Journal of Medicine,
369(6), 540-548.
[87] Giacco, F., & Brownlee, M. (2010). Oxidative stress and
diabetic complications. Circulation Research, 107(9), 1058-1070.
[88] Rawlings, A. M., Sharrett, A. R., Schneider, A. L., et al. (2014).
Diabetes in midlife and cognitive change over 20 years: a cohort
study. Annals of Internal Medicine, 161(11), 785-793.
[89] Brownlee, M. (2001). Biochemistry and molecular cell biology
of diabetic complications. Nature, 414(6865), 813-820.
[90] Montgomery, M. K., & Turner, N. (2015). Mitochondrial
dysfunction and insulin resistance: an update. Endocrine
Connections, 4(1).
[91] Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A.,
Treacher, D. F., & Turner, R. C. (1985). Homeostasis model
assessment: insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man. Diabetologia,
28(7), 412-419.
[92] Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004). Use and
abuse of HOMA modeling. Diabetes Care, 27(6), 1487-1495.
903
